RM
+
Packaging for risankizumab autoinjector pen Marketed as Skyrizi Risankizumab is a humanised monoclonal antibody that binds to interleukin 23A (IL-23
RM
+
Hand holding a risankizumab autoinjector pen Marketed as Skyrizi Risankizumab is a humanised monoclonal antibody that binds to interleukin 23A (IL-2
RM
+
Packaging for risankizumab autoinjector pen box Marketed as Skyrizi Risankizumab is a humanised monoclonal antibody that binds to interleukin 23A (I
RM
+
35 year old male patient self injecting using a Risankizumab (trade name Skyrizi) pen Risankizumab is a humanised monoclonal antibody that binds to i
RM
+
35 year old male patient self injecting using a Risankizumab (trade name Skyrizi) pen Risankizumab is a humanised monoclonal antibody that binds to i
ED
+
Editorial use only Cosentyx psoriasis treatment autoinjector Psoriasis is a skin condition where excessive growth of skin cells can lead to itchy
ED
+
Editorial use only Patient injecting himself with the psoriasis drug Cosentyx Psoriasis is a skin condition where excessive growth of skin cells ca
ED
+
Editorial use only Patient injecting himself with the psoriasis drug Cosentyx Psoriasis is a skin condition where excessive growth of skin cells ca
ED
+
Immunotherapy in cancer treatment use of a syringe to remove purified lymphocytes from a blood bag prior to doping with Interleukin-2 (IL- 2) IL-2
ED
+
Interleukin-6 Molecular model of a molecule of the cytokine protein interleukin-6 This protein is produced in the body and has a wide variety of fun
RM
+
Patient holding a pre-filled pen of Risankizumab medication Marketed as Skyrizi Risankizumab is a humanised monoclonal antibody that binds to interl
RM
+
Pre-filled pen of Risankizumab medication Marketed as Skyrizi Risankizumab is a humanised monoclonal antibody that binds to interleukin 23A (IL-23A)
RM
+
Packaging for the drug risankizumab Marketed as Skyrizi Risankizumab is a humanised monoclonal antibody that binds to interleukin 23A (IL-23A) and b
RM
+
Packaging for risankizumab medication Marketed as Skyrizi Risankizumab is a humanised monoclonal antibody that binds to interleukin 23A (IL-23A) and
ED
+
False-colour transmission electron micrograph (TEM) showing the bacterium Escherichia coli in the process of synthesising human Interleukin-2 (IL-2)
ED
+
Interleukin-6 (IL-6) molecular structure computer artwork This is a protein of the immune system The amino acid structure is shown in stick and bal
ED
+
Interleukin protein Computer graphic of the crystal structure of interleukin 10 a protein which plays a part in the bodys immune system Like all p
ED
+
Immunotherapy child suffering from cancer receiving infusion of lymphocytes doped with Interleukin-2 (IL-2) IL-2 is released naturally by certain ke
ED
+
Immune system response Artwork representing the activation of a T-lymphocyte cell (bottom right) due to the presence of a foreign cell (top left) Th
19
0
https://www.afloimages.com/search/interleukin%2023a.html